ELIZABETH RHOADES: Open Payments
NPI 1871945873 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$895 in 45 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $895
Food & beverage: $895
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $255 |
| UCB, Inc. | 7 | $167 |
| PFIZER INC. | 13 | $162 |
| Lundbeck LLC | 3 | $83 |
| ARGENX US, INC. | 2 | $59 |
| Alexion Pharmaceuticals, Inc. | 2 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: QULIPTA, NURTEC ODT, Zilbrysq, VYEPTI, VYVGART HYTRULO, BOTOX, UBRELVY, ULTOMIRIS.
Industry payments across GA — which companies pay providers there.
